K72.0 Acute and subacute hepatic failure

Name of the Condition

• Acute and Subacute Hepatic Failure (ICD-10 Code: K72.0)

Summary

Acute and subacute hepatic failure is a severe condition characterized by the rapid or progressive loss of liver function, typically occurring within weeks to months. This impairment affects the liver's ability to perform critical metabolic, detoxification, and synthetic functions, leading to systemic complications. The condition may present with jaundice, coagulopathy, and hepatic encephalopathy, and requires prompt medical evaluation.

Causes

The causes of acute and subacute hepatic failure include viral hepatitis (e.g., hepatitis B or E), drug-induced liver injury (e.g., acetaminophen overdose), autoimmune hepatitis, or acute fatty liver of pregnancy. Other triggers may involve ischemic injury, metabolic disorders, or vascular events affecting hepatic blood flow. In some cases, the underlying cause remains unidentified.

Risk Factors

• Viral infections (e.g., hepatitis B, E, or herpes simplex virus).
• Excessive alcohol consumption or drug toxicity (e.g., acetaminophen, certain antibiotics).
• Pre-existing liver disease (e.g., cirrhosis) or metabolic disorders.
• Pregnancy-related conditions (e.g., acute fatty liver of pregnancy).
• Exposure to hepatotoxic substances or environmental toxins.

Symptoms

• Jaundice (yellowing of the skin and eyes).
• Abdominal pain, swelling, or tenderness.
• Confusion, drowsiness, or altered mental status (hepatic encephalopathy).
• Easy bruising or bleeding due to coagulopathy.
• Fatigue, nausea, or loss of appetite.
• Dark urine or pale stools.

Diagnosis

Diagnosis involves a combination of clinical assessment, laboratory tests (e.g., liver function tests, coagulation studies), and imaging (e.g., ultrasound or CT scan) to evaluate liver structure and function. Additional tests may include viral serologies, toxicology screens, or liver biopsy to identify the underlying cause. Prompt recognition is critical to guide management.

Treatment Options

Treatment focuses on supportive care, including monitoring and managing complications (e.g., encephalopathy, coagulopathy). Specific interventions may involve antiviral therapy, discontinuation of hepatotoxic agents, or addressing metabolic derangements. In severe cases, liver transplantation may be considered. Nutritional support and avoidance of further liver injury are essential.

Prognosis and Follow-Up

Prognosis depends on the underlying cause, severity of liver dysfunction, and timely intervention. Acute cases may resolve with treatment, while subacute failure often has a poorer outcome. Follow-up includes regular monitoring of liver function, imaging, and assessment for complications. Long-term management may involve lifestyle modifications and ongoing medical care.

Complications

• Hepatic encephalopathy (neurological impairment).
• Coagulopathy leading to bleeding.
• Renal failure (hepatorenal syndrome).
• Infection due to impaired immune function.
• Multi-organ failure in advanced cases.

Lifestyle & Prevention

• Avoid alcohol and hepatotoxic medications.
• Maintain a balanced diet and healthy weight.
• Practice safe hygiene to prevent viral hepatitis.
• Get vaccinated against hepatitis A and B if at risk.
• Regularly review medications with a healthcare provider.

When to Seek Professional Help

Seek immediate medical attention for symptoms like jaundice, confusion, severe abdominal pain, or uncontrolled bleeding. Prompt evaluation is critical to prevent progression and initiate appropriate treatment.

Tips for Medical Coders

When coding K72.0, ensure documentation specifies "acute" or "subacute" hepatic failure and confirms the absence of chronic liver disease (e.g., cirrhosis) to distinguish it from chronic liver failure. Verify the underlying cause (e.g., viral, toxic) is documented, as this may impact coding specificity. Follow guidelines for coding complications (e.g., hepatic encephalopathy) separately if applicable.